- Treatment of blepharospasm with botulinum A toxin
-
Kim YD, Levine MR
- KMID: 1735008
- Korean J Ophthalmol.
- 1987 Dec;1(2):102-108.
- doi: 10.3341/kjo.1987.1.2.102
Thirty-nine patients with blepharospasm were treated with botulinum A toxin. Twenty-six patients had essential blepharospasm, and thirteen had a hemifacial spasm. A total of 113 injections were given, and the... -
- CITED
-
- Close
- SHARE
-
- Close
- Botulinum a toxin treatment of hemifacial spasm and blepharospasm
-
Park YC, Lim JK, Lee DK, Yi SD
- KMID: 1422000
- J Korean Med Sci.
- 1993 Oct;8(5):334-340.
- doi: 10.3346/jkms.1993.8.5.334
We studied the effects of botulinum A toxin in 101 patients with hemifacial spasm and 11 patients with blepharospasm in an open trial and double blind manner. All patients in... -
- CITED
-
- Close
- SHARE
-
- Close
- The Changes in Corneal Astigmatism after Botulinum Toxin-A Injection in Patients with Blepharospasm
-
Moon NJ, Lee HI, Kim JC
- KMID: 2157796
- J Korean Med Sci.
- 2006 Feb;21(1):131-135.
- doi: 10.3346/jkms.2006.21.1.131
To determine if the involuntary contractions of eyelids may have any effects on the development of corneal astigmatism, we performed this prospective study which includes 19 patients with either essential... -
- CITED
-
- Close
- SHARE
-
- Close
- Double-Blind, Randomized, Comparative Study of Meditoxin(R) Versus Botox(R) in the Treatment of Essential Blepharospasm
-
Yoon JS, Kim JC, Lee SY
- KMID: 1115742
- Korean J Ophthalmol.
- 2009 Sep;23(3):137-141.
- doi: 10.3341/kjo.2009.23.3.137
PURPOSE: To compare the efficacies and safeties of Meditoxin(R) (Medy-Tox, Korea) and Botox(R) in the treatment of essential blepharospasm. METHODS: We performed a double-blind, randomized, comparative trial comparing Meditoxin(R) and... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Outcomes of Individualized Botulinum Neurotoxin Type A Injection Techniques in Patients with Essential Blepharospasm
-
Sung Y, Nam SM, Lew H
- KMID: 2363717
- Korean J Ophthalmol.
- 2015 Apr;29(2):115-120.
- doi: 10.3341/kjo.2015.29.2.115
PURPOSE: To assess the clinical outcomes following botulinum neurotoxin type A (BoNT-A) treatment with an individualized injection technique based on the types of spasms and to compare the results of... -
- CITED
-
- Close
- SHARE
-
- Close
